- Q1 2024 Voyager Therapeutics Inc Earnings Call TranscriptMay 13, 2024$8.48 (+0.47%)Earnings
- Q4 2023 Voyager Therapeutics Inc Earnings Call TranscriptFeb 28, 2024$8.97 (+0.67%)Earnings
- Voyager Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Voyager Therapeutics Inc Earnings Call TranscriptNov 06, 2023$6.49 (-3.28%)Earnings
- Q2 2023 Voyager Therapeutics Inc Earnings Call TranscriptAug 03, 2023$9.31 (+3.44%)Earnings
- Voyager Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Voyager Therapeutics Inc Earnings Call TranscriptMay 09, 2023$10.76 (+29.48%)Earnings
- Q4 2022 Voyager Therapeutics Inc Earnings Call TranscriptMar 07, 2023$7.34 (-7.79%)Earnings
- Voyager Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Voyager Therapeutics Inc To Discuss Strategic Collaboration With Neurocrine Biosciences Inc Call TranscriptJan 09, 2023
- Q3 2022 Voyager Therapeutics Inc Earnings Call TranscriptNov 08, 2022$5.25 (+9.60%)Earnings
- Q2 2022 Voyager Therapeutics Inc Earnings Call TranscriptAug 04, 2022$7.47 (+5.66%)Earnings
- Q4 2021 Voyager Therapeutics Inc Earnings Call TranscriptMar 08, 2022$5.24 (+33.33%)Earnings
- Voyager Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q4 2020 Voyager Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$6.23 (-5.46%)Earnings
- Voyager Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Q4 2019 Voyager Therapeutics Inc Earnings Call TranscriptMar 03, 2020$11.58 (+2.16%)Earnings
- Voyager Therapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 Voyager Therapeutics Inc Earnings Call TranscriptNov 06, 2019$13.77 (-7.34%)Earnings
- Voyager Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Voyager Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Voyager Therapeutics Inc Earnings Call TranscriptAug 09, 2019$20.53 (-0.73%)Earnings
Voyager Therapeutics Inc To Discuss Strategic Collaboration With Neurocrine Biosciences Inc Call Transcript
Good morning, and welcome to Voyager Therapeutics conference call to discuss today's announcement of a strategic collaboration with Neurocrine Biosciences. (Operator Instructions) Please be advised that this call is being recorded at the company's request. A replay of today's call will be available on the Investors section of the company's website approximately 2 hours after completion of this call. I would now like to turn the call over to Pete Pfreundschuh, Chief Financial Officer. Please go ahead.
Thank you, and good morning. Earlier this morning, we issued a joint press release with Neurocrine, announcing a strategic collaboration between the 2 companies for the development and commercialization of Voyager's GBA1 program, 3 additional CNS rare disease gene therapy targets. This press release is available on our website.
On today's call, we will review highlights from the strategic collaboration and discuss the transformational value that this brings Voyager. We will also provide an update on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)